Latest News

Outset Medical (NASDAQ:OM) reported third-quarter 2026 revenue of $33.6 million, up 14% from a year earlier, as sales of its Tablo dialysis consoles increased and recurring revenue grew. The company reiterated its full-year revenue guidance of $125 million to $130 million. Revenue also rose 6% sequ

PROCEPT BioRobotics (NASDAQ:PRCT) reported 18% revenue growth in the third quarter of 2026 as demand for its HYDROS systems and procedure-related products helped offset slower-than-expected placements at new U.S. accounts. The company maintained its full-year revenue outlook and said it expects to

Sight Sciences (NASDAQ:SGHT) raised its full-year revenue outlook after reporting record third-quarter sales, driven by growth in its glaucoma business and increased adoption of its TearCare dry eye treatment. Revenue for the quarter ended September 30, 2026, rose 25% from a year earlier to $24.9 m

Woodside Energy Group (NYSE:WDS) outlined a new shareholder distribution policy and capital allocation framework at its 2026 Capital Markets Day, as the energy producer targets higher returns from major oil and liquefied natural gas projects. Chief Executive Officer and Managing Director Liz Westco

Power Integrations (NASDAQ:POWI) reported higher third-quarter revenue and earnings as demand for gallium nitride products and industrial applications offset weakness in appliances. The company also forecast fourth-quarter revenue growth from a year earlier, while cautioning that elevated channel in

Remitly Global (NASDAQ:RELY) reported record third-quarter revenue and adjusted earnings as customers sent more money through its network, while management outlined plans to invest in business payments and cards alongside its core remittance operations. Revenue rose 22% year over year to $510 milli

PureCycle Technologies (NASDAQ:PCT) reported lower third-quarter revenue after production problems at its Ironton plant and a New Jersey regulatory delay disrupted its sales plans. Management said the issues have been resolved, but the company no longer expects to reach its previously discussed prod

Precigen (NASDAQ:PGEN) reported $72.9 million in third-quarter 2026 sales of PAPZIMEOS, its treatment for adults with recurrent respiratory papillomatosis, as the company posted a second consecutive profitable quarter and generated positive cash flow ahead of its prior expectations. Sales of PAPZIM

Progyny (NASDAQ:PGNY) raised the midpoint of its full-year 2026 guidance after reporting record third-quarter revenue and profitability and securing a record 1.3 million new covered lives during its latest selling season. The fertility and family-building benefits company expects the majority of th

Red Violet (NASDAQ:RDVT) reported record third-quarter revenue and operating cash flow as demand for its identity intelligence services grew across its markets, though its IDI real estate business remained under pressure. Revenue rose 20% from a year earlier to $27.8 million, while operating cash f

Historically, stocks have soared in the third year of a presidential term.

The margin story rests on a 98% franchised target, and whether baseline traffic can carry that model through 2028 is still open.

Tens of thousands of cell sites start going up in 2027. How much of that belongs in the stock price now?

IonQ trades at a premium, while SoundHound AI shows a clearer path to profitability.

Intuitive Machines went flat for two years before tripling revenue, while Rocket Lab grew steadily -- but the gap is closing fast.

The chipmaker now expects its revenue to rise over 80% next year. What's a fair price to pay for that?

Korean retail margins are pegged to a mid-2027 recovery, while Taiwan logistics spending is being pulled forward ahead of demand.

Nuclear stocks are in a sell-off, and there might be opportunities for investors at these prices.

Sidekick's cost per conversation fell 28% even as merchant chats rose, a sign the AI assistant may scale without eroding margins.

Sezzle (NASDAQ:SEZL) raised its 2026 outlook after third-quarter revenue rose 42.6% and net income climbed 79.3%, as growth in subscriptions and transaction volume helped drive higher profitability. The company reported revenue of $166.5 million and net income of $47.8 million for the quarter. Adju

Nature's Sunshine Products (NASDAQ:NATR) lowered its full-year 2026 sales and earnings outlook after third-quarter revenue fell 9%, as weakness in China and Taiwan and a slowdown in its North American digital business weighed on results. Net sales for the quarter ended September 30 were $116.6 mill

Sera Prognostics (NASDAQ:SERA) reported a sharp increase in use of its PreTRM preterm birth risk test in the third quarter of 2026, as the company expanded its commercial efforts in Illinois and Florida following Medicaid coverage decisions in both states. Test volume rose 54% from the second quart

QuinStreet (NASDAQ:QNST) reported record revenue and adjusted earnings for its fiscal first quarter of 2027, driven by demand from auto insurers and growth in home services, and raised its outlook for the full year. Revenue increased 46% from a year earlier to $416.7 million in the September quarte

Schrodinger (NASDAQ:SDGR) raised its full-year 2026 outlook for annual contract value and drug discovery revenue after reporting third-quarter growth in both software demand and revenue from its therapeutics collaborations. The company reported total revenue of $64.5 million for the quarter, up 19%

Pattern Group (NASDAQ:PTRN) raised its full-year revenue and adjusted earnings outlook after reporting 38% revenue growth in the third quarter of 2026, as it signed more large brand partners and expanded beyond Amazon. The e-commerce services company reported revenue of $886 million and net income